Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)

NCT05120284 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT05120284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05120284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)
Lead sponsor
University of Florida
Phase
Phase 2
Overall status
Active, not recruiting
Start date
July 1, 2022
Completion date
August 31, 2026
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma multiforme